← Search & browse all drugs
CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › CAPILLARY STABILIZING AGENTS › Other capillary stabilizing agents
Hippocastani semen
C05CX03
Forms & Strengths
- Standardized seed extract capsules (typically 250-300 mg, equivalent to 50 mg aescin)
- Topical gels and creams (usually 2% aescin)
Adult Dosing
- Oral: 50 mg aescin (approx. 250-300 mg standardized extract) twice daily
- Topical: Apply gel/cream to affected area 3-4 times daily
Pediatric Dosing
- Safety and efficacy not established in pediatric patients under 18 years
Indications
- Chronic venous insufficiency (CVI)
- Varicose veins
- Leg heaviness, pain, and nocturnal cramping
- Post-operative or post-traumatic edema
Mechanism of Action
- Inhibits lysosomal enzymes (hyaluronidase, elastase) that degrade the endothelial glycocalyx of capillary walls
- Reduces vascular permeability, preventing fluid filtration into the interstitial space
- Increases venous tone via prostaglandin F2alpha release
Contraindications
- Known hypersensitivity to horse chestnut (Aesculus hippocastanum) or related plants
- Severe renal impairment
- Severe hepatic impairment
- Pregnancy and lactation due to insufficient safety data
Adverse Reactions
- Gastrointestinal upset (nausea, dyspepsia)
- Pruritus
- Dizziness
- Headache
- Allergic contact dermatitis (with topical application)
Drug Interactions
- Potential enhancement of anticoagulant and antiplatelet agents (warfarin, aspirin) due to theoretical bleeding risk
- May potentially increase nephrotoxicity when combined with aminoglycoside antibiotics
Curated Content: Needs Vetting Before Put to Clinical Use